{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-072962","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.935677+00:00","generated_at":"2026-06-25T00:28:23.918174+00:00","sec_items":["3.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aziyo appoints Dr. C. Randal Mills Interim CEO, Ronald Lloyd steps down; reaffirms FY22 guidance $47-50M","bullets":["CEO Ronald Lloyd steps down effective June 21; co-founder C. Randal Mills appointed Interim President and CEO.","Mills receives $600k base salary, 60% target bonus, option to purchase 456,278 shares, and 224,734 RSUs with time/performance vesting.","Lloyd remains employee through Sep 30 for transition; eligible for 12-month cash severance plus up to $1M performance bonus.","Mills' move from Audit Committee leaves it with two independent members; Nasdaq cure period of 180 days.","Company reaffirms FY2022 net sales guidance of $47–$50 million."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-072962","json":"https://secwatch.observer/filing/0001104659-22-072962.json","markdown":"https://secwatch.observer/filing/0001104659-22-072962.md","text":"https://secwatch.observer/filing/0001104659-22-072962.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922072962/0001104659-22-072962-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922072962/tm2218923d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:28:23.918174+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4fbdd855a3","claim":"Ronald Lloyd departed as President and Chief Executive Officer at ELUTIA INC..","evidence_excerpt":"Ronald Lloyd, who will be stepping down as the Company’s President and Chief Executive Officer and as a member of the Board, in each case, effective June 21, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922072962/0001104659-22-072962-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ec746af907","claim":"C. Randal Mills was appointed as Interim President and Chief Executive Officer at ELUTIA INC..","evidence_excerpt":"On June 20, 2022, C. Randal Mills, Ph.D., a member of the Board of Directors (the “Board”) of Aziyo Biologics, Inc. (the “Company”), was appointed as the Company’s Interim President and Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922072962/0001104659-22-072962-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}